C-reactive protein, established risk factors and social inequalities in cardiovascular disease – the significance of absolute versus relative measures of disease

[1]  Bernard Dixon,et al.  A Global Challenge , 2008 .

[2]  G. Berglund,et al.  The role of low grade inflammation as measured by C-reactive protein levels in the explanation of socioeconomic differences in carotid atherosclerosis. , 2007, European journal of public health.

[3]  P. Muennig,et al.  Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES. , 2007, Preventive medicine.

[4]  G. Berglund,et al.  Elevated Lp-PLA2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Strachan,et al.  Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population , 2007, Circulation.

[6]  B. Hedblad,et al.  The role of preclinical atherosclerosis in the explanation of educational differences in incidence of coronary events. , 2006, Atherosclerosis.

[7]  Lu Tian,et al.  Predicting cardiovascular risk: so what do we do now? , 2006, Archives of Internal Medicine.

[8]  S. Harper,et al.  Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches , 2006, Journal of Epidemiology and Community Health.

[9]  B. Hedblad,et al.  Occupation, Marital Status, and Low-Grade Inflammation: Mutual Confounding or Independent Cardiovascular Risk Factors? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  D. Lawlor,et al.  Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Jánosi.  [Epidemiology and prevention of cardiovascular diseases]. , 2005, Orvosi hetilap.

[12]  D. Lawlor,et al.  Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors , 2005, Thrombosis and Haemostasis.

[13]  G. Berglund,et al.  Blood Pressure Control and Risk of Stroke: A Population-Based Prospective Cohort Study , 2005, Stroke.

[14]  Giuseppe Costa,et al.  Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations , 2005, The Lancet.

[15]  K. Eriksson,et al.  Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. , 2005, Diabetes.

[16]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[17]  V. Salomaa,et al.  Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status , 2003, Journal of epidemiology and community health.

[18]  A. Steptoe,et al.  Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress , 2003, Brain, Behavior, and Immunity.

[19]  B. Hedblad,et al.  Inflammation-sensitive plasma proteins are associated with future weight gain. , 2003, Diabetes.

[20]  M. Rosén,et al.  Measuring social inequalities in health - politics or science? , 2003, Scandinavian journal of public health.

[21]  A. Térent,et al.  Case ascertainment in stroke studies: the risk of selection bias , 2003, Acta neurologica Scandinavica.

[22]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[23]  G. Berglund,et al.  Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  GunnarEngström,et al.  Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins , 2002 .

[25]  Russell Senior,et al.  A Population-Based Prospective Cohort Study of Personal Exposure to Magnetic Fields during Pregnancy and the Risk of Miscarriage , 2002, Epidemiology.

[26]  R. Beaglehole,et al.  The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. , 2001, Archives of internal medicine.

[27]  G. Berglund,et al.  The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[28]  N Rifai,et al.  Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. , 2001, Clinical chemistry.

[29]  G. Berglund,et al.  Occupational status, educational level, and the prevalence of carotid atherosclerosis in a general population sample of middle-aged Swedish men and women: results from the Malmö Diet and Cancer Study. , 2000, American journal of epidemiology.

[30]  P. Nilsson,et al.  Relation between insulin resistance and carotid intima‐media thickness and stenosis in non‐diabetic subjects. Results from a cross‐sectional study in Malmö, Sweden , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[31]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[32]  F. Nieto.  Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. , 1999, American journal of public health.

[33]  L. Janzon,et al.  Intra-urban variations in incidence and mortality in myocardial infarction. A study from the myocardial infarction register in the city of Malmö, Sweden. , 1998, European heart journal.

[34]  A. Ahlbom,et al.  Socioeconomic differences in risk of myocardial infarction 1971-1994 in Sweden: time trends, relative risks and population attributable risks. , 1998, International journal of epidemiology.

[35]  J. Mackenbach,et al.  Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies , 1998, BMJ.

[36]  J. Hallqvist.  Socioeconomic differences in myocardial infarction risk : Epidemiological analyses of causes and mechanisms , 1998 .

[37]  S. Syme,et al.  Rethinking disease: where do we go from here? , 1996, Annals of epidemiology.

[38]  J E Keil,et al.  Socioeconomic factors and cardiovascular disease: a review of the literature. , 1993, Circulation.

[39]  M. Pepys,et al.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. , 1993, The Journal of clinical investigation.

[40]  J. Salonen,et al.  Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. , 1993, American journal of epidemiology.

[41]  G. Berglund,et al.  Design and feasibility , 1993 .

[42]  S. Fortmann,et al.  Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. , 1992, American journal of public health.

[43]  G. Berglund,et al.  Stroke Registry in Malmö, Sweden , 1992, Stroke.

[44]  S Greenland,et al.  Concepts of interaction. , 1980, American journal of epidemiology.

[45]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[46]  F. Khan.  Epidemiology of stroke in an urban population - aspects of time, place and person , 2004 .

[47]  L. Kuller.  Epidemiology and Prevention of Cardiovascular Diseases: A Global Challenge , 2002 .

[48]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. , 1999, Lancet.

[49]  J. Mackenbach,et al.  The size of mortality differences associated with educational level in nine industrialized countries. , 1994, American journal of public health.

[50]  G. Berglund,et al.  The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.